Tranexamic acid decreases blood loss after total shoulder arthroplasty

Journal of Shoulder and Elbow Surgery

Volumn 25, Issue 4, 2016, Pages 614-618

  Friedman, Richard J ^a   Gordon, Eric ^a   Butler, R Bryan ^a   Mock, Lisa ^a   Dumas, Bonnie ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Anatomic shoulder arthroplasty; Blood loss; Blood transfusion; Patient outcomes; Reverse shoulder arthroplasty; Total shoulder arthroplasty; Tranexamic acid

Indexed keywords

HEMOGLOBIN; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ANALYSIS OF VARIANCE; ARTICLE; BLEEDING; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HEMATOCRIT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE SHOULDER ARTHROPLASTY; SHOULDER ARTHROPLASTY; TREATMENT OUTCOME; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; INTRAVENOUS DRUG ADMINISTRATION; POSTOPERATIVE HEMORRHAGE; REPLACEMENT ARTHROPLASTY; RETROSPECTIVE STUDY; SHOULDER; SURGERY;

ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LENGTH OF STAY; MALE; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES; SHOULDER JOINT; TRANEXAMIC ACID;

EID: 84960481296     PISSN: 10582746     EISSN: 15326500     Source Type: Journal    
DOI: 10.1016/j.jse.2015.09.014     Document Type: Article

References (40)

1. Aguilera X., Videla S., Almenara M., Fernandez J.A., Gich I., Celaya F. Effectiveness of tranexamic acid in revision total knee arthroplasty. Acta Orthop Belg 2012, 78:68-74.
2. Alshryda S., Sukeik M., Sarda P., Blenkinsopp J., Haddad F.S., Mason J.M. A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement. Bone Joint J 2014, 96-B:1005-1015. 10.1302/0301-620x.96b8.33745.
3. Álvarez J.C., Santiveri F.X., Ramos I., Vela E., Puig L., Escolano F. Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied. Transfusion 2008, 48:519-525. 10.1111/j.1537-2995.2007.01564.x.
4. Banerjee S., Issa K., Kapadia B.H., Khanuja H.S., Harwin S.F., McInerney V.K., et al. Intraoperative nonpharmacotherapeutic blood management strategies in total knee arthroplasty. J Knee Surg 2013, 26:387-393. 10.1055/s-0033-1353993.
5. Banerjee S., Issa K., Pivec R., McElroy M.J., Khanuja H.S., Harwin S.F., et al. Intraoperative pharmacotherapeutic blood management strategies in total knee arthroplasty. J Knee Surg 2013, 26:379-385. 10.1055/s-0033-1353992.
6. Benoni G., Fredin H. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. J Bone Joint Surg Br 1996, 78:434-440.
7. Cherian J.J., Banerjee S., Kapadia B.H., Sodhi G.S., Issa K., Harwin S.F., et al. Nonsurgical intra-operative blood management strategies for total hip arthroplasty. Surg Technol Int 2014, 24:326-332.
8. Cherian J.J., Kapadia B.H., Banerjee S., Jauregui J., Issa K., Harwin S.F., et al. Surgical intra-operative blood management strategies for total hip arthroplasty. Surg Technol Int 2014, 24:319-325.
9. Cid J., Lozano M. Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials. Transfusion 2005, 45:1302-1307. 10.1111/j.1537-2995.2005.00204.x.
10. Cole J.W., Murray D.J., Snider R.J., Bassett G.S., Bridwell K.H., Lenke L.G. Aprotinin reduces blood loss during spinal surgery in children. Spine 2003, 28:2482-2485. 10.1097/01.brs.0000090835.45437.7f.
11. Copley L.A., Richards B.S., Safavi F.Z., Newton P.O. Hemodilution as a method to reduce transfusion requirements in adolescent spine fusion surgery. Spine 1999, 24:219-222.
12. Dunn C.J., Goa K.L. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999, 57:1005-1032.
13. Ellis M.H., Fredman B., Zohar E., Ifrach N., Jedeikin R. The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. J Clin Anesth 2001, 13:509-513.
14. Eubanks J.D. Antifibrinolytics in major orthopaedic surgery. J Am Acad Orthop Surg 2010, 18:132-138.
15. Fergusson D.A., Hebert P.C., Mazer C.D., Fremes S., MacAdams C., Murkin J.M., et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008, 358:2319-2331. 10.1056/NEJMoa0802395.
16. Friedman R., Homering M., Holberg G., Berkowitz S.D. Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. J Bone Joint Surg Am 2014, 96:272-278. 10.2106/jbjs.l.01268.
17. Geerts W.H., Bergqvist D., Pineo G.F., Heit J.A., Samama C.M., Lassen M.R., et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133(Suppl):381s-453s. 10.1378/chest.08-0656.
18. George D.A., Sarraf K.M., Nwaboku H. Single perioperative dose of tranexamic acid in primary hip and knee arthroplasty. Eur J Orthop Surg Traumatol 2015, 25:129-133. 10.1007/s00590-014-1457-5.
19. Gillespie R.J., Shishani Y., Hanzlik S., Streit J.J., Gobezie R. A randomized, prospective evaluation on the effectiveness of tranexamic acid in reducing blood loss after total shoulder arthroplasty. J Shoulder Elbow Surg 2015, 24:e234. 10.1016/j.jse.2015.05.009.
20. Good L., Peterson E., Lisander B. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br J Anaesth 2003, 90:596-599.
21. Haas S.B., Barrack R.L., Westrich G. Venous thromboembolic disease after total hip and knee arthroplasty. Instr Course Lect 2009, 58:781-793.
22. Hardy J.F., Belisle S. Natural and synthetic antifibrinolytics in adult cardiac surgery: efficacy, effectiveness and efficiency. Can J Anaesth 1994, 41:1104-1112.
23. Ho K.M., Ismail H. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: a meta-analysis. Anaesth Intensive Care 2003, 31:529-537.
24. Huang F., Wu D., Ma G., Yin Z., Wang Q. The use of tranexamic acid to reduce blood loss and transfusion in major orthopedic surgery: a meta-analysis. J Surg Res 2014, 186:318-327. 10.1016/j.jss.2013.08.020.
25. Irisson E., Hemon Y., Pauly V., Parratte S., Argenson J.N., Kerbaul F. Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. Orthop Traumatol Surg Res 2012, 98:477-483. 10.1016/j.otsr.2012.05.002.
26. Jain N.B., Yamaguchi K. The contribution of reverse shoulder arthroplasty to utilization of primary shoulder arthroplasty. J Shoulder Elbow Surg 2014, 23:1905-1912. 10.1016/j.jse.2014.06.055.
27. Johanson N.A., Lachiewicz P.F., Lieberman J.R., Lotke P.A., Parvizi J., Pellegrini V., et al. American Academy of Orthopaedic Surgeons clinical practice guideline on. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Bone Joint Surg Am 2009, 91:1756-1757. 10.2106/jbjs.i.00511.
28. Kagoma Y.K., Crowther M.A., Douketis J., Bhandari M., Eikelboom J., Lim W. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res 2009, 123:687-696. 10.1016/j.thromres.2008.09.015.
29. Lozano M., Basora M., Peidro L., Merino I., Segur J.M., Pereira A., et al. Effectiveness and safety of tranexamic acid administration during total knee arthroplasty. Vox Sang 2008, 95:39-44. 10.1111/j.1423-0410.2008.01045.x.
30. Meert K.L., Kannan S., Mooney J.F. Predictors of red cell transfusion in children and adolescents undergoing spinal fusion surgery. Spine (Phila Pa 1976) 2002, 27:2137-2142.
31. Murray D.J., Forbes R.B., Titone M.B., Weinstein S.L. Transfusion management in pediatric and adolescent scoliosis surgery. Efficacy of autologous blood. Spine 1997, 22:2735-2740.
32. Orpen N.M., Little C., Walker G., Crawfurd E.J. Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients. Knee 2006, 13:106-110. 10.1016/j.knee.2005.11.001.
33. Poeran J., Rasul R., Suzuki S., Danninger T., Mazumdar M., Opperer M., et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ 2014, 349:g4829. 10.1136/bmj.g4829.
34. Ponnusamy K.E., Kim T.J., Khanuja H.S. Perioperative blood transfusions in orthopaedic surgery. J Bone Joint Surg Am 2014, 96:1836-1844. 10.2106/jbjs.n.00128.
35. Sukeik M., Alshryda S., Haddad F.S., Mason J.M. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br 2011, 93:39-46. 10.1302/0301-620x.93b1.24984.
36. Thompson G.H., Florentino-Pineda I., Poe-Kochert C. The role of Amicar in decreasing perioperative blood loss in idiopathic scoliosis. Spine (Phila Pa 1976) 2005, 30(Suppl):S94-S99. 10.1097/01.brs.0000175188.05542.a9.
37. Veien M., Sorensen J.V., Madsen F., Juelsgaard P. Tranexamic acid given intraoperatively reduces blood loss after total knee replacement: a randomized, controlled study. Acta Anaesthesiol Scand 2002, 46:1206-1211.
38. Zhang H., Chen J., Chen F., Que W. The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc 2012, 20:1742-1752. 10.1007/s00167-011-1754-z.
39. Zhou X.D., Tao L.J., Li J., Wu L.D. Do we really need tranexamic acid in total hip arthroplasty? A meta-analysis of nineteen randomized controlled trials. Arch Orthop Trauma Surg 2013, 133:1017-1027. 10.1007/s00402-013-1761-2.
40. Zohar E., Ellis M., Ifrach N., Stern A., Sapir O., Fredman B. The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement. Anesth Analg 2004, 99:1679-1683. 10.1213/01.ane.0000136770.75805.19.